U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523347) titled 'Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis' on April 04.
Brief Summary: The study seeks to fill the gaps regarding safety and efficacy of rivaroxaban and standard anticoagulant. therefore the current study was planned with the aim to determine the safety and efficacy of rivaroxaban and standard anticoagulant in the treatment of cerebrosinovenous thrombosis (CSVT).
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Cerebrosinovenous Thrombosis
Intervention:
DRUG: Rivaroxaban
Children were treated initially with low molecular weight heparin (LMWH) for 7 to 10 days followed by ora...